Literature DB >> 34796409

Integrative Analysis of the Expression of microRNA, Long Noncoding RNA, and mRNA in Osteoarthritis and Construction of a Competing Endogenous Network.

Juntan Li1, Xiang Gao2, Wannan Zhu3, Xu Li4.   

Abstract

This study aimed to identify potential core microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and mRNAs in osteoarthritis (OA) to construct a competing endogenous RNA (ceRNA) and co-expression network. Differentially expressed miRNAs (DEMis) in the dataset GSE143514 comprising five OA and three normal tissues were identified using the DEseq package. Core miRNAs were identified as DEMis overlapping with those reported by the human microRNA disease database. LncRNAs were predicted by the miRNA-lncRNA interactions network from the encyclopedia of RNA interactomes (ENCORI). MiRNet and ENCORI were employed to predict the mRNAs which overlapped with the differentially expressed mRNAs from the dataset GSE114007 to obtain overlapping mRNAs. MiRNA-lncRNA and miRNA-mRNA interactions were integrated to construct the ceRNA network. A total of 143 DEMis were identified in OA and normal tissues, from which hsa-miR-451a, hsa-miR-370-5p, hsa-miR-34a-5p, hsa-miR-210-3p, and hsa-miR-101-3p were assessed as core miRNAs using overlapping analyses. These RNAs may represent potential therapeutic targets for the treatment of OA.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cartilage; Functional annotation; Osteoarthritis; ceRNA; miRNA

Mesh:

Substances:

Year:  2021        PMID: 34796409     DOI: 10.1007/s10528-021-10159-3

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   2.220


  50 in total

Review 1.  miRNome in myocardial infarction: Future directions and perspective.

Authors:  Emanuela Boštjančič; Damjan Glavač
Journal:  World J Cardiol       Date:  2014-09-26

Review 2.  Review of current understanding of post-traumatic osteoarthritis resulting from sports injuries.

Authors:  Andrew Carbone; Scott Rodeo
Journal:  J Orthop Res       Date:  2016-07-22       Impact factor: 3.494

3.  LncRNA FOXD2-AS1 regulates chondrocyte proliferation in osteoarthritis by acting as a sponge of miR-206 to modulate CCND1 expression.

Authors:  Lei Cao; Yang Wang; Qiugen Wang; Jianhua Huang
Journal:  Biomed Pharmacother       Date:  2018-07-19       Impact factor: 6.529

Review 4.  Long noncoding RNAs: a new regulatory code in osteoarthritis.

Authors:  Xiao Cen; Xin-Qi Huang; Wen-Tian Sun; Qing Liu; Jun Liu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 5.  Origins and Mechanisms of miRNAs and siRNAs.

Authors:  Richard W Carthew; Erik J Sontheimer
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

Review 6.  A systems view of risk factors for knee osteoarthritis reveals insights into the pathogenesis of the disease.

Authors:  Thomas P Andriacchi; Julien Favre; J C Erhart-Hledik; Constance R Chu
Journal:  Ann Biomed Eng       Date:  2014-09-16       Impact factor: 3.934

Review 7.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

8.  A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA.

Authors:  Marcella Cesana; Davide Cacchiarelli; Ivano Legnini; Tiziana Santini; Olga Sthandier; Mauro Chinappi; Anna Tramontano; Irene Bozzoni
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

9.  miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology.

Authors:  Le Chang; Guangyan Zhou; Othman Soufan; Jianguo Xia
Journal:  Nucleic Acids Res       Date:  2020-07-02       Impact factor: 16.971

10.  An integrated analysis of the competing endogenous RNA network and co-expression network revealed seven hub long non-coding RNAs in osteoarthritis.

Authors:  Haitao Chen; Liaobin Chen
Journal:  Bone Joint Res       Date:  2020-05-16       Impact factor: 5.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.